Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

RxSight, Inc. - Common Stock (NQ:RXST)

7.900 -4.890 (-38.23%)
Streaming Delayed Price Updated: 3:23 PM EDT, Jul 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about RxSight, Inc. - Common Stock

< Previous 1 2 Next >
RxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Revised 2025 Guidance
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Reports First Quarter 2025 Financial Results
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Present at the Bank of America Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Reports Third Quarter 2024 Financial Results
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Reports Second Quarter 2024 Financial Results
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. To Participate in the Truist Securities Medtech Conference
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Announces Pricing of Public Offering of Common Stock
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Announces Proposed Public Offering of Common Stock
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Reports First Quarter 2024 Financial Results
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Present at the Bank of America Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
From RxSight, Inc.
Via GlobeNewswire
RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
From RxSight, Inc.
Via GlobeNewswire
Insiders are selling these hot stocks on track for higher prices
Insiders are selling these hot stocks and may cap gains in the near term, but long-term gains are in the outlook. Analysts support them and raise their targets. 
Via MarketBeat
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance
From RxSight, Inc.
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.